Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis

Background: Long-acting injectable (LAI) aripiprazole was found to be efficacious in schizophrenia. In common clinical practice, the use of LAIs is often restricted to chronic patients with frequent relapses and poor adherence. Recently, some investigators advanced the idea of early LAI use also in...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Gloria, Tomassini, Lorenzo, Cuomo, Ilaria, Amici, Emanuela, Perrini, Filippo, Callovini, Gemma, Carannante, Alfonso, Kotzalidis, Georgios D., De Filippis, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960223/
https://www.ncbi.nlm.nih.gov/pubmed/31969843
http://dx.doi.org/10.3389/fpsyt.2019.00935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960223/
https://www.ncbi.nlm.nih.gov/pubmed/31969843
http://dx.doi.org/10.3389/fpsyt.2019.00935

Ejemplares similares